NASDAQ:ADTX Aditxt (ADTX) Stock Price, News & Analysis $5.00 +0.48 (+10.62%) Closing price 04:00 PM EasternExtended Trading$4.76 -0.24 (-4.70%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock About Aditxt Stock (NASDAQ:ADTX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Aditxt alerts:Sign Up Key Stats Today's Range$4.36▼$5.4450-Day Range$4.37▼$32.1552-Week Range$4.11▼$54,500.00Volume197,008 shsAverage Volume724,365 shsMarket Capitalization$285,000.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewAditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.Read More… Remove Ads Aditxt Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks16th Percentile Overall ScoreADTX MarketRank™: Aditxt scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Aditxt. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Book Value per Share RatioAditxt has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Aditxt's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.85% of the float of Aditxt has been sold short.Short Interest Ratio / Days to CoverAditxt has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aditxt has recently decreased by 99.70%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAditxt does not currently pay a dividend.Dividend GrowthAditxt does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.85% of the float of Aditxt has been sold short.Short Interest Ratio / Days to CoverAditxt has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aditxt has recently decreased by 99.70%, indicating that investor sentiment is improving significantly. News and Social Media1.7 / 5News Sentiment0.03 News SentimentAditxt has a news sentiment score of 0.03. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for Aditxt this week, compared to 1 article on an average week.Search InterestOnly 29 people have searched for ADTX on MarketBeat in the last 30 days. This is a decrease of -42% compared to the previous 30 days.MarketBeat FollowsOnly 9 people have added Aditxt to their MarketBeat watchlist in the last 30 days. This is a decrease of -36% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Aditxt insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.01% of the stock of Aditxt is held by insiders.Percentage Held by InstitutionsOnly 15.54% of the stock of Aditxt is held by institutions.Read more about Aditxt's insider trading history. Receive ADTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aditxt and its competitors with MarketBeat's FREE daily newsletter. Email Address ADTX Stock News HeadlinesAditxt, Inc. Updates on Pearsanta’s Strategic AcquisitionMarch 31 at 9:15 AM | tipranks.comUpcoming Aditxt Weekly Update to Highlight Pearsanta's Acquisition of the Adductomics-Based CaSe Platform and its Potential for Early Cancer DetectionMarch 28, 2025 | businesswire.comElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.April 2, 2025 | Brownstone Research (Ad)Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Decline in Short InterestMarch 28, 2025 | americanbankingnews.comAditxt Subsidiary Pearsanta Acquires Key Patents For Early Cancer DetectionMarch 26, 2025 | nasdaq.comEvofem Reports Fourth Consecutive Year of Net Sales GrowthMarch 24, 2025 | finance.yahoo.comAditxt, Inc. Highlights Strategic Partnership with EvofemMarch 24, 2025 | tipranks.comAditxt Insider Trading Activity | NASDAQ:ADTX | BenzingaMarch 19, 2025 | benzinga.comSee More Headlines ADTX Stock Analysis - Frequently Asked Questions How have ADTX shares performed this year? Aditxt's stock was trading at $47.45 on January 1st, 2025. Since then, ADTX stock has decreased by 89.5% and is now trading at $5.00. View the best growth stocks for 2025 here. How were Aditxt's earnings last quarter? Aditxt, Inc. (NASDAQ:ADTX) released its quarterly earnings results on Wednesday, August, 11th. The company reported ($8,400,000.00) EPS for the quarter, missing the consensus estimate of ($1,000,000.00) by $7,400,000.00. When did Aditxt's stock split? Aditxt's stock reverse split on the morning of Monday, March 17th 2025. The 1-250 reverse split was announced on Wednesday, March 12th 2025. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 14th 2025. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split. How do I buy shares of Aditxt? Shares of ADTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Aditxt own? Based on aggregate information from My MarketBeat watchlists, some other companies that Aditxt investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Plug Power (PLUG), SNDL (SNDL), AMC Entertainment (AMC) and Walt Disney (DIS). Company Calendar Last Earnings8/11/2021Today4/02/2025Next Earnings (Estimated)4/15/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:ADTX CIK1726711 Webwww.aditxt.com Phone650-870-1200FaxN/AEmployees60Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-32,380,000.00 Net MarginsN/A Pretax Margin-30,525.09% Return on Equity-439.07% Return on Assets-122.96% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.08 Sales & Book Value Annual Sales$212,107.00 Price / Sales1.39 Cash FlowN/A Price / Cash FlowN/A Book Value$2,687.49 per share Price / Book0.00Miscellaneous Outstanding Shares57,000Free Float14,233,000Market Cap$294,120.00 OptionableNo Data Beta1.27 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:ADTX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aditxt, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aditxt With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.